Skip to content

Clinical study on glycemic excursion improvements with a fixed mitiglinide / voglibose combination in patients with type 2 diabetic mellitus(T2DM) - research into glycemic excursion-improving mechanisms -

Clinical study on glycemic excursion improvements with a fixed mitiglinide / voglibose combination in patients with type 2 diabetic mellitus(T2DM) - research into glycemic excursion-improving mechanisms - - Clinical study on glycemic excursion-improving mechanisms in the T2DM patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010409
Enrollment
12
Registered
2013-04-03
Start date
2013-03-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T2DM

Interventions

After an observation period, the combination will be administered for 4 weeks, and meal load tests will be done using unified meals at the clinic before and after 4-weeks treatment.

Sponsors

Yuri Ono Clinic, Diabetes, Internal Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)T2DM patients treated with a diabetic diet and exercise regimens for their diabetes, or, patients for whom a washout period or 4 weeks or more can be established for any hypoglycemic agent they have been treated with, other than an SU or insulin 2)Patients able to take the test meals 3)Patients age 20 years or older 4)Patients to whom the significance, objectives and methods of this study have been explained, and from whom consent can be willingly obtained

Exclusion criteria

Exclusion criteria: 1)Patients to whom [Contraindications] in labeling for the combination apply 2)Any others who the principal investigator deems unsuitable as subjects, in consideration of any [Special caution needed] in labeling for the combination

Design outcomes

Primary

MeasureTime frame
Efficacy endpoints are various metabolic parameter measures as well as changes from baseline and their AUC before and after 4-weeks treatment with the combination, and over 120 minutes after meals in the morning, afternoon and evening meals

Countries

Japan

Contacts

Public ContactErika Yamagishi

Yuri Ono Clinic, Diabetes, Internal Medicine Yuri Ono Clinic, Diabetes, Internal Medicine

erika-yamagishi@npo-acro.jp011-223-5152

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026